Delivering a smoke-free future
Our current product portfolio primarily consists of cigarettes and smoke-free products, including heated tobacco, e-vapor, and oral smokeless products.
In 2021, 29.1 percent of our total net revenues came from our smoke-free products.
By 2025, our target is to increase that figure to at least 50 percent, with the ultimate goal of phasing out cigarettes completely. We also aim for USD 1 billion in annual net revenues to come from wellness and healthcare products.

FAQs
From company information to our smoke-free portfolio, we answer frequently asked questions.
Find out more